John W. Shiver - 03 Jan 2022 Form 4 Insider Report for Icosavax, Inc.

Role
Director
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
4
Filing time
05 Jan 2022, 18:34:08 UTC
Next filing
14 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Award $0 +8,500 $0.000000 8,500 03 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Award $0 +25,500 $0.000000 25,500 03 Jan 2022 Common Stock 25,500 $22.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted on January 3, 2022. 1/3 of the total number of RSUs granted vest on each of the first three anniversaries of January 3, 2022, the vesting commencement date, subject to the reporting person's continued service on the applicable vesting date. Vesting of the RSUs shall accelerate upon a Change of Control (as defined in the Icosavax, Inc. 2021 Incentive Award Plan). Each RSU represents a contingent right to receive one share of common stock of the Issuer.
F2 1/36th of the shares subject to the option vest monthly following January 3, 2022, the vesting commencement date.